Literature DB >> 7758476

D-arabinitol versus mannan antigen and candidal protein antigen as a serum marker for Candida pyelonephritis.

S Tokunaga1, M Ohkawa, M Takashima, C Seto, S Nakamura.   

Abstract

To evaluate serum markers for the diagnosis of Candida pyelonephritis, levels of D-arabinitol, candidal mannan antigen and candidal protein antigen were measured using an enzymatic fluorometric assay, an enzyme immunoassay and a latex agglutination assay, respectively. The study group comprised 36 patients with candiduria (11 disseminated candidiasis, 9 Candida pyelonephritis and 16 colonization) and 27 without candiduria. The D-arabinitol/creatinine ratio was the only marker that differentiated between Candida pyelonephritis and colonization (p < 0.01). Using the cut-off values (1.4 mumol/mg of D-arabinitol/creatinine ratio, 0.28 of mannan/creatinine ratio (x 10(4)) and 1:4 of protein antigen titer) D-arabinitol/creatinine ratio showed the highest sensitivity in Candida pyelonephritis (77.8%) as compared to mannan/creatinine ratio (55.6%) and protein antigen titer (11.1%) although there were no differences in specificity, positive predictive value or negative predictive value. These results suggest that D-arabinitol/creatinine ratio is the most useful marker of Candida pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758476     DOI: 10.1007/BF02111869

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Clinical significance of measurement of serum D-arabinitol levels in candiduria patients.

Authors:  S Tokunaga; M Ohkawa; M Takashima; H Hisazumi
Journal:  Urol Int       Date:  1992       Impact factor: 2.089

2.  Enzymatic fluorometric method for the determination of D-arabinitol in serum by initial rate analysis.

Authors:  K Soyama; E Ono
Journal:  Clin Chim Acta       Date:  1985-07-15       Impact factor: 3.786

3.  Advances in the diagnosis of renal candidiasis.

Authors:  P J Kozinin; C L Taschdjian; P K Goldberg; G J Wise; E F Toni; M S Seelig
Journal:  J Urol       Date:  1978-02       Impact factor: 7.450

4.  Mannan and D-arabinitol concentrations in serum from a patient with Candida albicans endocarditis.

Authors:  S Fujita; K Maeno; K Soyama
Journal:  Mycopathologia       Date:  1989-02       Impact factor: 2.574

5.  Collaborative evaluation of antigen detection by a commercial latex agglutination test and enzyme immunoassay in the diagnosis of invasive candidiasis.

Authors:  C Lemieux; G St-Germain; J Vincelette; L Kaufman; L de Repentigny
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Diagnostic value of determination of serum mannan concentrations in patients with candiduria.

Authors:  S Tokunaga; M Ohkawa; M Takashima
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

7.  Circulating Candida antigens and antibodies: useful markers of candidemia.

Authors:  J Gutiérrez; C Maroto; G Piédrola; E Martín; J A Perez
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Serum levels of arabinitol in the detection of invasive candidiasis in animals and humans.

Authors:  R H Eng; H Chmel; M Buse
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

9.  Rate of arabinitol production by pathogenic yeast species.

Authors:  E M Bernard; K J Christiansen; S F Tsang; T E Kiehn; D Armstrong
Journal:  J Clin Microbiol       Date:  1981-08       Impact factor: 5.948

10.  Candidal antigenemia: a prognostic determinant.

Authors:  T Suits; G J Wise; B Walters
Journal:  J Urol       Date:  1989-06       Impact factor: 7.450

View more
  2 in total

Review 1.  Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients.

Authors:  M Kalin; B Petrini
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

Review 2.  Current status of nonculture methods for diagnosis of invasive fungal infections.

Authors:  Siew Fah Yeo; Brian Wong
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.